Souders Financial Advisors Seagen Inc. Transaction History

Souders Financial Advisors

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$117.37 - $139.17 $40,492 - $48,013	345 Added 8.67%	4,322 $555,000
Q3 2022 Nov 10, 2022	SELL	$135.27 - $180.11 $137,028 - $182,451	-1,013 Reduced 20.3%	3,977 $544,000
Q2 2022 Aug 05, 2022	BUY	$108.81 - $179.33 $4,352 - $7,173	40 Added 0.81%	4,990 $883,000
Q1 2022 May 04, 2022	BUY	$119.61 - $157.85 $101,070 - $133,383	845 Added 20.58%	4,950 $713,000
Q4 2021 Feb 04, 2022	SELL	$142.57 - $190.86 $72,140 - $96,575	-506 Reduced 10.97%	4,105 $635,000

Q3 2021 Nov 03, 2021	BUY	$142.45 - $169.82 $656,836 - $783,040	4,611 New	4,611 $783,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Souders Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Souders Financial Advisors with notifications on news.